CAN ALFENTANIL OR DILTIAZEM PREVENT MYOCARDIAL ISCHEMIA DUE TO TRACHEAL INTUBATION?

Abstract

Objective: The aim of this study is to evaluate the efficacy of alfentanil and diltiazem to attenuate the cardiovascular responses to laryngoscopy and tracheal intubation and their effects on the occurrance of myocardial ischemia in patients with coronary artery disease.
Methods: Twenty eight patients ASA ll-lll, 40-80 years old, scheduled for elective abdominal surgery were randomly assigned into three groups. Anesthesia was induced with 0.2 mg/kg etomidate and 1.5 mg/kg succinylcholine i.v. in all patients. In group I (n=10) 15 pg/kg alfentanil i.v. and in group II (n=10) 0.2 mg/kg diltiazem i.v. were administered 2 minutes before laryngoscopy. In group III (n=8) (control) no medication was administered. Systolic, diastolic, mean arterial pressure, heart rate, rate-pressure product and ST segment changes in Dll and V5 leads were recorded before and after induction at 1., 3., 5. minutes of intubation.
Results: Mean arterial pressure was significantly lower in the alfentanil and diltiazem group 1 minute after intubation. There was no significant difference in heart rate between groups. Rate-pressure product was greater than 11000 in all patients of diltiazem and control groups and in 9 patients of alfentanil group.
Conclusion: Although 0.2 mg/kg diltiazem and 15 pg/kg alfentanil i.v. attenuated the hypertensive response to tracheal intubation, they were found to be ineffective in decreasing the incidence of myocardial ischemia in coronary artery disease.
Key Words: Myocardial ischemia, alfentanil, diltiazem. Tracheal intubation, hemodynamic response.

References

1. /. Hartley M, Vaughan RS. Problems associated with tracheal extubation. Br J Anaesth 1993; 71:561- 568
2. Kaplan JA, King SB. The precordial electrocardiographic lead (V5) in patients who have coronary artery disease. Anesthesiology 1976; 45:570-574.
3. Carliner HH, Fisher ML. Routine preoperative exercise testing in patients undergoing major noncardiac surgery. Am J Cardiol 1985; 56:51-57.
4. Fleisher LA, Longstan M. Perioperative ST segment changes in moderate risk asymptomatic individuals may not be myocardial ischemia. Anesth Anaig 1995; 80-.SCA9.
5. Mangano DT, Browner tVS. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in man undergoing noncardiac surgery, H Eng J Med 1990; 323:1781- 1788.
6. Hicks HJ, Mowbray A. Cardiovascular effects of and cathecoiamine responses to high dose fentanyl-02 for induction of anaesthesia in patients with ischemic coronary artery disease. Anesth Anaig 1981; 60:563-568.
7. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics and rational opioid selection. Anesthesiology 1981; 74:53-63.
8. rieedlman P. Drugs used for the treatment of angina: organic nitrates, calcium channel blockers and beta adrenergic antagonists. In: AG Gilman, LS Goodman. The Pharmacological Basis of Therapeutics. Hew York: McMillan, 1985: 806-826

9. Harris CE, Murray JM. Effects of thiopentone, etomidate and propofol on the hemodynamic response to tracheal intubation. Anaesthesia 1988; 43:32-36.
10. Mikawa K, Ikegaki J. The effects of diltiazem on cardiovascular response to tracheal intubation. Anaesthesia 1990; 45:289-293.
11. I. Miller DR, Martineau RJ. Effects of alfentanil on the hemodynamic and cathecoiamine response to tracheal intubation. Anesth Anaig 1993, 76:1040- 1046.
12. Ray WL, Edelist G. Myocardial ischemia during noncardiac surgial procedures in patients with coronary artery disease. Anesthesiology 1979; 51:393-397.
13. Rifkin DR, Hood WB. Bayesian analysis of electrocardiographic exercise stress testing. H Eng J Med 1977, 297:681-686.